Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain

June 24, 2010 updated by: Hamilton Health Sciences Corporation

The purpose of the proposed study is to evaluate the efficacy of the InterX 5000 in relieving chronic neck and shoulder pain. This study will focus on the efficacy of treating patients who have functional limitations in activity because of chronic/recurrent neck or shoulder pain.

H1: InterX therapy will have a moderate effect to reduce pain.

H2: Functional gains will be greater in patients receiving InterX therapy compared to those who received placebo treatment.

H3: Chronic neck and shoulder pain is more prevalent in patients who exhibit radiographic evidence of degenerative spondylosis/arthrosis of the cervical spine.

Study Overview

Detailed Description

Electrical stimulation modalities of various types have been used as a therapeutic intervention for years in a wide variety of applications. Individuals with neck and shoulder pain represent a significant segment of the pain population seeking relief. However, there is a paucity of data from quality studies published in mainstream peer-reviewed journals supporting the effectiveness of this intervention. No well-designed prospective, randomized, controlled trials investigating the efficacy or effectiveness of this intervention in patients with chronic neck and shoulder pain have been reported. The need for such work is becoming increasingly important considering the progressively greater demands for evidence-based medicine to justify reimbursement for care.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8S 1C7
        • McMaster University
      • Toronto, Ontario, Canada, M2H 3J1
        • Canadian Memorial Chiropractic College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • chronic or recurrent neck or shoulder pain of at least 3 months duration with or without arm pain
  • willing to sign consent for study participation
  • able/willing to comply with treatment schedule

Exclusion Criteria:

  • clinically significant herniated disc (defined as positive radicular arm pain aggravated by head position change or neural stretch signs from provocative arm movement, this will not exclude patients with any imaged herniation as this is a common finding in all populations)
  • spinal fracture
  • previous electrical stimulation treatment for this episode
  • recent cervical spinal or shoulder surgery or implanted instrumentation/prostheses.
  • patients with cardiac pacemaker or spinal cord stimulator, epilepsy, pregnancy, recent (3 months) chemotherapy/radiotherapy, phlebitis, cortisone use (30 days)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
InterX treatment plus rehabilitation exercises
Patients will receive will receive InterX treatment 3 times a week for 4 weeks.
Placebo Comparator: 2
Inactive InterX treatment plus rehabilitation exercises
Patients will receive will receive InterX placebo treatment 3 times a week for 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Visual Analog Scale
Time Frame: 4 weeks
4 weeks
Neck Disability Index (NDI)
Time Frame: 4 weeks
4 weeks
Medical Outcomes Study Short-Form 36 (SF-36) Health Survey
Time Frame: 4 weeks
4 weeks
Short-Form McGill Questionnaire
Time Frame: 4 weeks
4 weeks
Biomarkers (inflammatory cytokines and SP)
Time Frame: 4 weeks
4 weeks
Functional Impairment Test-Hand, and Neck, Shoulder, Arm (FIT-HaNSA)
Time Frame: 4 weeks
4 weeks
Cervical Range of Motion (CROM)
Time Frame: 4 weeks
4 weeks
Grip strength
Time Frame: 4 weeks
4 weeks
Vibration threshold
Time Frame: 4 weeks
4 weeks
Pain Tolerance and Threshold - Pressure
Time Frame: 4 weeks
4 weeks
Pain Threshold and Tolerance - Current Perception
Time Frame: 4 weeks
4 weeks
Current Perception Threshold
Time Frame: 4 weeks
4 weeks
Neck Walk Index (NWI)
Time Frame: 4 weeks
4 weeks
Muscle Fatigue
Time Frame: 4 weeks
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Linda J Woodhouse, PhD, McMaster University
  • Principal Investigator: John J Triano, DC, PhD, Canadian Memorial Chiropractic College
  • Principal Investigator: Vickie Galea, PhD, McMaster University
  • Principal Investigator: H Stephen Injeyan, PhD, DC, Canadian Memorial Chiropractic College
  • Principal Investigator: Joy MacDermid, PhD, McMaster University
  • Principal Investigator: Marion McGregor, DC, PhD, Canadian Memorial Chiropractic College
  • Principal Investigator: Michael Pierrynowski, PhD, McMaster University
  • Principal Investigator: Richard Ruegg, PhD, DC, Canadian Memorial Chiropractic College
  • Principal Investigator: Julita A Teodorczyk-Injeyan, PhD, Canadian Memorial Chiropractic College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

August 1, 2009

Study Completion (Actual)

December 1, 2009

Study Registration Dates

First Submitted

December 21, 2007

First Submitted That Met QC Criteria

December 21, 2007

First Posted (Estimate)

January 7, 2008

Study Record Updates

Last Update Posted (Estimate)

June 25, 2010

Last Update Submitted That Met QC Criteria

June 24, 2010

Last Verified

June 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Pain

Clinical Trials on InterX 5000 Treatment

3
Subscribe